Skip to main content

Table 1 Demographic and clinical characteristics of stroke patients.

From: Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke

Characteristic

Good Recovery (mRS ≤ 1)

Poor Recovery (mRS>1)

P*

Age and Gender

   

   Age, mean ± SD (yrs)

50.8 ± 9

52.5 ± 8.5

0.028

   Gender (male), n/N (%)

174/276 (63.0)

174/270 (64.4)

0.734

Past History, n/N (%)

   

   Hypertension

159/241 (66.0)

143/240 (59.6)

0.147

   Diabetes

36/259 (13.9)

47/246 (19.1)

0.115

   Cardiac Disease

37/264 (14.0)

43/257 (16.7)

0.390

Sroke type, n/N (%)

   

   Ischemic stroke

238/276 (86.2)

193/270 (71.5)

-

   Hemorrhagic stroke

33/276 (12.0)

72/270 (26.7)

-

   Unknow type of stroke

5/276 (1.8)

5/270 (1.9)

-

Stroke Features, n/N (%)

   

   Aphasia

53/258 (20.5)

98/250 (39.2)

4.23 × 10-6

   Neglect

11/266 (4.1)

19/240 (7.9)

0.072

   Dysphagia

15/270 (5.6)

25/251 (10.0)

0.059

   Urinary Incontinence

5/272 (1.8)

15/251 (6.0)

0.014

   Paresis

203/273 (74.4)

244/269 (90.7)

5.59 × 10-7

   Consciousness disturbance

21/275 (7.6)

59/265 (22.3)

1.72 × 10-6

   Medical complications

18/265 (6.8)

82/254 (32.3)

1.83 × 10-13

   Neurologic complications

14/274 (5.1)

39/267 (14.6)

2.03 × 10-4

  1. *Mann-Whitney test or χ2 test.
  2. SD - standard deviation, yrs - years.